Efficacy and safety of carboplatin with nab-paclitaxel versus docetaxel in older patients with squamous non-small-cell lung cancer (CAPITAL): a randomised, multicentre, open-label, phase 3 trial — New Breathe
Phase I study of weekly nab-paclitaxel plus carboplatin and concurrent thoracic radiotherapy in elderly patients with unresectable locally advanced non-small cell lung cancer | springermedizin.de
Paclitaxel – Wikipedia
Health-Related Quality of Life With Carboplatin-Paclitaxel or nab-Paclitaxel With or Without Pembrolizumab in Patients With Metastatic Squamous Non–Small-Cell Lung Cancer | Journal of Clinical Oncology
Successful chemotherapy with carboplatin and nab-paclitaxel for thymic large cell neuroendocrine carcinoma: A case report
Chemotherapie | PINK! Brustkrebs
Carboplatin and nab-paclitaxel chemotherapy with or without atezolizumab as front-line management for treatment-naïve metastatic nonsquamous non-small cell lung cancer with PD-L1 staining: a retrospective study | Journal of Cancer Research and Clinical
Pembrolizumab + Chemotherapie beim NSCLC – gemeinsame Stellungnahmen von DGHO und AIO — Deutsche Gesellschaft für Hämatologie und med. Onkologie e.V.
Phase II study of carboplatin/nab-paclitaxel/atezolizumab combination therapy for advanced nonsquamous non–small cell lung cancer patients with impaired renal function: RESTART trial | BMC Cancer | Full Text
Nab-Paclitaxel/Bevacizumab/Carboplatin Chemotherapy in First-Line Triple Negative Metastatic Breast Cancer - ScienceDirect
A phase II study of concurrent nab-paclitaxel/carboplatin combined with thoracic radiotherapy in locally advanced squamous cell lung cancer - Wu - Journal of Thoracic Disease
IMpower131: Final OS Results of Carboplatin + Nab-Paclitaxel ± Atezolizumab in Advanced Squamous NSCLC on Vimeo
Efficacy and safety of carboplatin with nab-paclitaxel versus docetaxel in older patients with squamous non-small-cell lung cancer (CAPITAL): a randomised, multicentre, open-label, phase 3 trial - The Lancet Healthy Longevity
EP305/#335 Short-course of nab-paclitaxel plus carboplatin in first-line advanced ovarian cancer treatment: a multicenter, nonrandomized controlled, phase II study | International Journal of Gynecologic Cancer
A randomised phase II clinical trial of nab-paclitaxel and carboplatin compared with gemcitabine and carboplatin as first-line therapy in advanced squamous cell lung carcinoma (C-TONG1002) - ScienceDirect
nab-Paclitaxel + Carboplatin bei fortgeschrittenem NSCLC (kartoniertes Buch) | Schwäbischer Albverein e.V.
Dose Delivery Nab-Paclitaxel Carboplatin | Download Scientific Diagram
A phase II study of nab-paclitaxel and carboplatin chemotherapy plus necitumumab in the first-line treatment of patients with stage IV squamous non-small cell lung cancer - ScienceDirect
Longer OS with atezolizumab + carboplatin + nab-paclitaxel in advanced squamous NSCLC - Medical Conferences
Health-Related Quality of Life With Carboplatin-Paclitaxel or nab-Paclitaxel With or Without Pembrolizumab in Patients With Metastatic Squamous Non–Small-Cell Lung Cancer | Journal of Clinical Oncology
Pharmaceuticals | Free Full-Text | Development and Evaluation of a Quantitative Systems Pharmacology Model for Mechanism Interpretation and Efficacy Prediction of Atezolizumab in Combination with Carboplatin and Nab- Paclitaxel in Patients with Non ...
Frontiers | Consolidation With Pembrolizumab and Nab-Paclitaxel After Induction Platinum-Based Chemotherapy for Advanced Non-Small Cell Lung Cancer
Treatment schema. Patients received nab-paclitaxel (30 or 40 mg/m²) and... | Download Scientific Diagram
Erstlinientherapie beim fortgeschrittenem NSCLC: Nab-Paclitaxel - das innovative und effektivere Taxan
nab-Paclitaxel plus carboplatin or gemcitabine versus gemcitabine plus carboplatin as first-line treatment of patients with triple-negative metastatic breast cancer: results from the tnAcity trial - Annals of Oncology
